Literature DB >> 2951373

T3-p28 is a protein associated with the delta and epsilon chains of the T cell receptor-T3 antigen complex during biosynthesis.

C L Pettey, B Alarcon, R Malin, K Weinberg, C Terhorst.   

Abstract

The human T cell receptor-T3 antigen complex is composed of at least five polypeptide chains. In addition to the 45-kDa/50-kDa heterodimer (alpha and beta chains) of the T cell receptor, the complex includes 25-kDa (T3-gamma) and 20-kDa (T3-delta) glycoproteins and a nonglycosylated 20-kDa (T3-epsilon) protein. Here we report that in pulse-chase biosynthetic labeling experiments we detect a new polypeptide chain (T3-p28) which is associated with the T3-delta and T3-epsilon chains during biosynthesis but not on the cell surface. T3-p28, which is not recognized by anti-T3 antibodies, can be chemically distinguished from the previously described T3-gamma chain. The carboxylic ionophore monensin blocks the apparent dissociation of T3-p28 from the T3-delta and T3-epsilon chains. Peripheral blood lymphocytes as well as all T cell leukemic lines tested contain T3-p28, except one HPB-ALL subline. Since the T3-p28 protein is only observed early in biosynthesis of T3-delta and T3-epsilon, it may function in intracellular transport or assembly of the T cell receptor-T3 complex.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2951373

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Close linkage of the mouse and human CD3 gamma- and delta-chain genes suggests that their transcription is controlled by common regulatory elements.

Authors:  H Saito; T Koyama; K Georgopoulos; H Clevers; W G Haser; T LeBien; S Tonegawa; C Terhorst
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

2.  Subunit interactions within the T-cell antigen receptor: clues from the study of partial complexes.

Authors:  J S Bonifacino; C Chen; J Lippincott-Schwartz; J D Ashwell; R D Klausner
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

3.  Cyclophilin B trafficking through the secretory pathway is altered by binding of cyclosporin A.

Authors:  E R Price; M Jin; D Lim; S Pati; C T Walsh; F D McKeon
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

4.  CD3-T cell receptor modulation is selectively induced in CD8 but not CD4 lymphocytes cultured in agar.

Authors:  N Oudrhiri; J P Farcet; M F Gourdin; E M'Bemba; P Gaulard; A Katz; M Divine; A Galazka; F Reyes
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

5.  Complexing of the CD-3 subunit by a monoclonal antibody activates a microtubule-associated protein 2 (MAP-2) serine kinase in Jurkat cells.

Authors:  C Hanekom; A Nel; C Gittinger; A Rheeder; G Landreth
Journal:  Biochem J       Date:  1989-09-01       Impact factor: 3.857

6.  Characterization and expression of the murine CD3-epsilon gene.

Authors:  H Clevers; S Dunlap; H Saito; K Georgopoulos; T Wileman; C Terhorst
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

7.  A CD8 polypeptide that is lost after passing the Golgi but before reaching the cell surface: a novel sorting mechanism.

Authors:  R Zamoyska; J R Parnes
Journal:  EMBO J       Date:  1988-08       Impact factor: 11.598

8.  Pre-Golgi degradation of newly synthesized T-cell antigen receptor chains: intrinsic sensitivity and the role of subunit assembly.

Authors:  J S Bonifacino; C K Suzuki; J Lippincott-Schwartz; A M Weissman; R D Klausner
Journal:  J Cell Biol       Date:  1989-07       Impact factor: 10.539

9.  T cell receptor (TCR) interacting molecule (TRIM), a novel disulfide-linked dimer associated with the TCR-CD3-zeta complex, recruits intracellular signaling proteins to the plasma membrane.

Authors:  E Bruyns; A Marie-Cardine; H Kirchgessner; K Sagolla; A Shevchenko; M Mann; F Autschbach; A Bensussan; S Meuer; B Schraven
Journal:  J Exp Med       Date:  1998-08-03       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.